Cas:53277-42-2 1-pyrrolo[2,3-b]pyridin-1-ylethanone manufacturer & supplier

We serve Chemical Name:1-pyrrolo[2,3-b]pyridin-1-ylethanone CAS:53277-42-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-pyrrolo[2,3-b]pyridin-1-ylethanone

Chemical Name:1-pyrrolo[2,3-b]pyridin-1-ylethanone
CAS.NO:53277-42-2
Synonyms:1-Acetyl-1,7-diazainden;N-acetyl-7-azaindole;1-Acetyl-7-azaindole;1-Acetyl-7-Azaindol;1-acetyl-1H-pyrrolo[2,3-b]pyridine;1-Acetyl-1H-pyrrolo[2,3-b]pyridin
Molecular Formula:C9H8N2O
Molecular Weight:160.17300
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:34.89000
Exact Mass:160.06400
LogP:1.69640

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Acetyl-1,7-diazainden chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Acetyl-1H-pyrrolo[2,3-b]pyridin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-acetyl-7-azaindole Use and application,1-acetyl-1H-pyrrolo[2,3-b]pyridine technical grade,usp/ep/jp grade.


Related News: ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 1-pyrrolo[2,3-b]pyridin-1-ylethanone manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations. 1-pyrrolo[2,3-b]pyridin-1-ylethanone supplier A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. 1-pyrrolo[2,3-b]pyridin-1-ylethanone vendor At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances. 1-pyrrolo[2,3-b]pyridin-1-ylethanone factory A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters.